Search results for "Neurologi"

showing 10 items of 1189 documents

Association between plasma lipid levels and migraine in subjects agedor =50 years: preliminary data from the Zabùt Aging Project.

2008

We evaluated the association between lipid levels and migraine using cross-sectional, population-based data of 1809 subjects aged >= 50 years; 151 subjects with migraine and 1658 nonmigraineurs were included. Diagnosis of migraine was carried out using the criteria of the International Headache Society. The following plasma lipids were collected: total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG). Only TC (p= 220 mg/dl) was significantly associated with migraine (OR [95% CI]=1.6 [1.1-2.3]); this association increased in elderly males with migraine (OR [95% CI]=3.8 [1.4-9.9]). According to our results, TC p…

Malemedicine.medical_specialtyMigraine DisordersPopulationDermatologychemistry.chemical_compoundTotal cholesterolInternal medicineEpidemiologyPlasma lipidsmedicineOdds RatioHumanseducationGeriatric AssessmentTriglyceridesLipoprotein cholesterolAgedRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industryCholesterolCholesterol HDLMigraine Epidemiology Cholesterol ElderlyAge FactorsGeneral MedicinePlasma levelsCholesterol LDLMiddle Agedmedicine.diseaseLipidsPsychiatry and Mental healthEndocrinologyMigrainechemistryItalylipids (amino acids peptides and proteins)Settore MED/26 - NeurologiaFemaleNeurology (clinical)businessNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Movements Execution in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

2007

We evaluated the relationship between motor and neuropsychological deficits in subjects affected by amnestic Mild Cognitive Impairment (aMCI) and early Alzheimer’s Disease (AD). Kinematics of goal-directed movement of aMCI and AD subjects were compared to those of age-matched control subjects. AD showed a slowing down of motor performance compared to aMCI and controls. No relationships were found between motor and cognitive performances in both AD and aMCI. Our results suggest that the different motor behaviour between AD and aMCI cannot be related to memory deficits, probably reflecting the initial degeneration of parietal-frontal circuits for movement planning. The onset of motor dysfunct…

Malemedicine.medical_specialtyMild Cognitive ImpairmentMotor dysfunctionneuropsychologyNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseAudiologyNeuropsychological TestsMotor behaviourSeverity of Illness Indexbehavioral disciplines and activitiesAlzheimer Diseasemental disordersmedicineReaction TimeHumansBiomechanicsClinical NoteAlzheimer’s DiseaseCognitive impairmentalzheimer's disease mild cognitive impairment kinematicsAgedDemographypointingMovement DisordersNeuropsychologyCognitionGeneral MedicineControl subjectsBiomechanical PhenomenaSeverity of Illness Index; Humans; Alzheimer Disease; Aged; Mental Recall; Cognition Disorders; Demography; Movement Disorders; Neuropsychological Tests; Amnesia; Biomechanics; Female; Male; Reaction TimeNeuropsychology and Physiological PsychologyNeurologykinematicsMental RecallSettore MED/26 - NeurologiaFemaleNeurology (clinical)AmnesiaPsychologyCognition DisordersNeuroscienceMovement planningRC321-571Behavioural Neurology
researchProduct

Predictors of progression from mild cognitive impairment to Alzheimer disease.

2007

Objective: To determine the occurrence of neuropsychiatric symptomatology and the relation to future development of Alzheimer disease (AD) in persons with and without mild cognitive impairment (MCI). Method: We followed 185 persons with no cognitive impairment and 47 with MCI (amnestic and multidomain), ages 75 to 95, from the population-based Kungsholmen Project, Stockholm, Sweden, for 3 years. Three types of neuropsychiatric symptoms were assessed at baseline: mood-related depressive symptoms, motivation-related depressive symptoms, and anxiety-related symptomatology. AD at 3-year follow-up was diagnosed according to Diagnostic and Statistical Manual for Mental Disorders-III-R criteria. R…

Malemedicine.medical_specialtyMild Cognitive ImpairmentPopulationNeuropsychological Testsbehavioral disciplines and activitiesDysphoriaCohort StudiesAlzheimer DiseasePredictive Value of TestsRisk FactorsInternal medicinemental disordersmedicinePrevalenceHumanseducationSuicidal ideationAgedAged 80 and overeducation.field_of_studyDepressive DisorderMood Disordersmedicine.diseaseAlzheimer's disease EpidemiologyComorbidityAnxiety DisordersMoodMood disordersDisease ProgressionAnxietySettore MED/26 - NeurologiaFemaleNeurology (clinical)medicine.symptomAlzheimer's diseasePsychologyCognition DisordersClinical psychologyNeurology
researchProduct

Epidemiology of multiple sclerosis in Sicily

2001

From epidemiological data obtained over more than 20 years by surveys conducted in different parts of Sicily, it is evident that Sicily is a high-risk area for multiple sclerosis (MS). This is in sharp contrast with the gradient hypothesis. High frequencies have been found in different parts of the island having different geoclimatic features, but at least two cities (Monreale and Enna) had had a prolonged Norman domination. This is in agreement with the hypothesis that MS originated in Northern Europe and spread around the world throughout the raids of the northern peoples. The increase in frequency estimated by follow-up and incidence studies is well established and is only in part linked…

Malemedicine.medical_specialtyMultiple SclerosisRange (biology)PrevalenceDermatologySex FactorsRisk FactorsEpidemiologymedicinePrevalenceHumansMultiple sclerosiSicilyNeuroscience (all)Multiple sclerosisIncidence (epidemiology)IncidenceAge FactorsGeneral Medicinemedicine.diseasePsychiatry and Mental healthGeographyFemaleSettore MED/26 - NeurologiaNeurology (clinical)CartographyFollow-Up Studies
researchProduct

Parkinson disease survival: a population-based study

2000

Objective To evaluate whether the survival of patients with Parkinson disease (PD) is shorter than that of the general population. Design Survival was investigated in a cohort of patients with PD previously identified during a population-based prevalence study (prevalence day, November 1, 1987; reference follow-up date, October 31, 1995). The survival of patients with PD was compared with that of a control sample randomly selected from the same population (2 controls for each case, matched for age, sex, and study municipality). The causes of death in the 2 groups were also compared. Both univariate and multivariate survival analyses were performed to investigate the association with disease…

Malemedicine.medical_specialtyMultivariate analysisHeart DiseasesPopulationComorbidityCohort StudiesLevodopaAge DistributionArts and Humanities (miscellaneous)Internal medicineCause of DeathmedicinePrevalenceHumansSex DistributioneducationSurvival rateSicilySurvival analysisCause of deathAgedProportional Hazards ModelsAged 80 and overUnivariate analysiseducation.field_of_studyNeuroscience (all)Proportional hazards modelbusiness.industryParkinson DiseasePneumoniaMiddle AgedSurvival AnalysisSurgerySurvival RateMultivariate AnalysisSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessCohort study
researchProduct

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

2011

none 25 no Abstract OBJECTIVES: To evaluate the incidence and dose-dependency of mitoxantrone (MTX)-associated acute myelocytic leukemia (AML) in the network of Italian multiple sclerosis (MS) clinics. METHODS: We performed a multicenter retrospective cohort study of patients treated with MTX in MS centers under the Italian national health care system between 1998 and 2008. Demographic, disease, treatment, and follow-up information were collected using hospital records. RESULTS: Data were available for 3,220 patients (63% women) from 40 Italian centers. Follow-up (mean ± SD) was 49 ± 29 months (range 12-140 months). We observed 30 cases of AML (incidence 0.93% [95% confidence interval 0.60%…

Malemedicine.medical_specialtyMyeloidmitoxantrone; acute myelocytic leukemia; multiple sclerosisPopulationmultiple sclerosisStatistics NonparametricmitoxantroneFollow-Up StudieArts and Humanities (miscellaneous)Retrospective StudieInternal medicineMultiple SclerosimedicineHumansmultiple sclerosis leukemia mitoxantroneProspective cohort studyeducationRetrospective StudiesAgedAnalgesicseducation.field_of_studyMitoxantroneCumulative dosebusiness.industryMultiple sclerosisIncidence (epidemiology)leukemiaMyeloid leukemiaRetrospective cohort studymedicine.diseaseConfidence intervalSurgeryLeukemiaLeukemia Myeloid Acutemedicine.anatomical_structureItalyCohortSettore MED/26 - NeurologiaAnalgesicFemaleNeurology (clinical)acute myelocytic leukemiaMitoxantronebusinessFollow-Up Studiesmedicine.drugHuman
researchProduct

Leprosy: report of a case with severe peripheral neuropathy

2009

Leprosy (Hansen's disease) is a chronic granulomatous infectious disease, caused by Mycobacterium leprae, with cutaneous and neurological manifestations. Leprosy is very rare in Europe but some cases are reported, especially among people coming from endemic areas. Here, we report a case of Hansen's disease and emphasize the importance of a prompt diagnosis and treatment also in non-endemic areas.

Malemedicine.medical_specialtyNeurologyAdolescentSensory Receptor CellsChronic granulomatousLeprosy neuropathyNeural ConductionDermatologyDiseaseLeprosymedicineHumansMuscle SkeletalSicilyMycobacterium lepraeMotor NeuronsbiologyElectromyographybusiness.industryPeripheral Nervous System DiseasesGeneral Medicinebiology.organism_classificationmedicine.diseaseDermatologySenegalPsychiatry and Mental healthPeripheral neuropathyInfectious disease (medical specialty)ImmunologySettore MED/26 - NeurologiaNeurology (clinical)LeprosyNeurosurgerybusinessNeurological Sciences
researchProduct

Auditory event-related potentials in subcortical vascular cognitive impairment and in Alzheimer's disease.

2006

Few studies exist on ERPs and patients with subcortical vascular cognitive impairment (SVCI). This latter is a quite homogeneous subtype of vascular dementia whose cognitive profile is quite different from that of Alzheimer disease (AD).The present study aims at comparing the ERPs profile both in patients with SVCI and in patients with AD.ERPs and psychometric tests were collected from 39 healthy elderly controls, 51 patients with SVCI and 43 patients with AD. Subjects mentally count high pitched target tones that were randomly intermixed with low pitched frequent tones. We measured ERPs latencies (N1, P2, N2 and P3), and interpeak latencies (N1-P3, N1-P2, N1-N2).Grand averaged potentials i…

Malemedicine.medical_specialtyNeurologyAuditory eventDiseaseNeuropsychological TestsDiagnosis DifferentialAlzheimer DiseasemedicineDementiaHumansCognitive impairmentVascular dementiavascular cognitive impairmentBiological PsychiatryAgedBrainCognitionmedicine.diseasePsychiatry and Mental healthCerebrovascular DisordersNeurologybehavior and behavior mechanismsEvoked Potentials AuditorySettore MED/26 - NeurologiaFemaleNeurology (clinical)Alzheimer's diseasePsychologyCognition DisordersNeuroscienceERPdementiaJournal of neural transmission (Vienna, Austria : 1996)
researchProduct

Generation and validation of algorithms to identify subjects with dementia using administrative data

2019

Objectives: To generate and validate algorithms for the identification of individuals with dementia in the community setting, by the interrogation of administrative records, an inexpensive and already available source of data. Methods: We collected and anonymized information on demented individuals 65 years of age or older from ten general practitioners (GPs) in the district of Brianza (Northern Italy) and compared this with the administrative data of the local health protection agency (Agenzia per la Tutela della Salute). Indicators of the disease in the administrative database (diagnosis of dementia in the hospital discharge records; use of cholinesterase inhibitors/memantine; neuropsycho…

Malemedicine.medical_specialtyNeurologyDatabases FactualAdministrative dataDermatologyDiseaseSensitivity and SpecificityMedical Records03 medical and health sciences0302 clinical medicineSensitivityCost of IllnessmedicinePrevalenceDementiaHumans030212 general & internal medicineMED/01 - STATISTICA MEDICANeuroradiologyAgedAged 80 and overMED/26 - NEUROLOGIAbusiness.industryMedical recordNeuropsychologyMemantineGeneral Medicinemedicine.diseaseAlgorithmPsychiatry and Mental healthItalySpecificityFemaleDementiaNeurology (clinical)NeurosurgerybusinessAlgorithm030217 neurology & neurosurgeryAlgorithmsmedicine.drug
researchProduct

Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects

2007

Dopaminergic drugs and deep brain stimulation restore cortical inhibition in Parkinson disease (PD) patients. High-frequency rTMS was also found to increase cortical inhibition in PD but its therapeutic effect is still controversial. Here we hypothesize that, if dopaminergic drugs reverse to normal cortical excitability in M1, the effect of high-frequency (hf)-rTMS in PD patients could depend on whether they are in a medicated or unmedicated state. The present study aims to explore the lasting effects of sub-threshold hf rTMS trains over M1 on cortical inhibition in patients with "on" and without "off" L-DOPA treatment. Fourteen PD patients were examined twice while "on" and "off" medicatio…

Malemedicine.medical_specialtyNeurologyDeep brain stimulationCORTICAL SILENT PERIODmedicine.medical_treatmentStimulationMotor ActivityInhibitory postsynaptic potentialPAIRED-PULSE INHIBITIONAntiparkinson AgentsLevodopaDegenerative diseaseEVOKED-POTENTIALSmedicineHumansCORTEX EXCITABILITYAgedAged 80 and overSUBTHALAMIC NUCLEUSPARKINSONS-DISEASE PATIENTSGeneral NeuroscienceDopaminergicMotor CortexNeural InhibitionParkinson DiseaseMiddle Agedmedicine.diseaseFACILITATIONCombined Modality TherapyTranscranial Magnetic StimulationTranscranial magnetic stimulationBRAIN-STIMULATIONmedicine.anatomical_structureSettore MED/26 - NeurologiaFemaleREPETITIVE TMSPsychologyNeuroscienceMotor cortexExperimental Brain Research
researchProduct